Results 211 to 220 of about 87,303 (273)

Distribution of CCR5-Delta32, CCR2-64I, and SDF1-3'A host genetic factors in HIV-infected and uninfected individuals in Luanda, Angola. [PDF]

AIDS Res Ther
Sebastião CS, Pimentel V, Jandondo D, Sebastião JMK, Sacomboio E, Pingarilho M, Brito M, Cassinela EK, de Vasconcelos JN, Abecasis AB, Morais J.   +10 more
europepmc   +1 more source

Synthesis of Peptides Mimicking Chemokine Receptor CCR5 and Their Inhibitory Effects against HIV-1 Infection.

, 2000
Koji Konishi, Kiyoshi Ikeda, Kazuo Achiwa, Hiroo Hoshino, Kiyoshi Tanaka   +4 more
openalex   +2 more sources

CCR5 Inhibitors and HIV-1 Infection

Journal of AIDS and HIV Treatment, 2018
Olga Latinovic, Alonso Heredia, Marvin S. Reitz   +2 more
openaire   +3 more sources

Correction: CXCL10-induced regulatory T cells and adenosine signaling promote immunosuppression and progression of epithelial ovarian cancer. [PDF]

Sci Rep
Lin AC, Moscarelli J, Zhu YL, Lin ZP, Ratner ES.   +4 more
europepmc   +1 more source

Novel HIV-1 co-receptor-CCR5 promoter mutations in simians: identification of two highly polymorphic regions with extensive deletions

, 2000
Shanmugasundaram Ganapathy‐Kanniappan, Nandini Ramamoorti, Akhil C. Banerjea   +2 more
openalex   +1 more source

Progress in structure-based drug development targeting chemokine receptors. [PDF]

Front Pharmacol
Wang J, Qu C, Xiao P, Liu S, Sun JP, Ping YQ.   +5 more
europepmc   +1 more source

V2 Loop Glycosylation of the Human Immunodeficiency Virus Type 1 SF162 Envelope Facilitates Interaction of This Protein with CD4 and CCR5 Receptors and Protects the Virus from Neutralization by Anti-V3 Loop and Anti-CD4 Binding Site Antibodies

, 2000
Amy Ly, Leonidas Stamatatos
openalex   +1 more source

Causal Pathways for CCR5 Genotype and HIV Progression

, 2000
Jeremy M. G. Taylor, Yan Wang, Linda Ahdieh, Joan S. Chmiel, Roger Detels, Janis V. Giorgi, Richard A. Kaslow, Lawrence Kingsley, Joseph B. Margolick   +8 more
openalex   +2 more sources

Human neutrophils are a cellular source of apolipoprotein A-I. [PDF]

J Leukoc Biol
Yao X, Mills J, Dagur PK, Lin WC, Lopez-Ocasio M, Gao M, Yu ZX, Takeda K, Keeran KJ, Kim IH, Barochia AV, Levine SJ.   +11 more
europepmc   +1 more source

Preclinical systematic review of CCR5 antagonists as cerebroprotective and stroke recovery enhancing agents. [PDF]

Elife
Sharif A, Jeffers MS, Fergusson DA, Bapuji R, Nicholls SG, Humphrey J, Johnston W, Mitchell E, Speirs MA, Stronghill L, Vuckovic M, Wulf S, Shorr R, Dowlatshahi D, Corbett D, Lalu MM.   +15 more
europepmc   +1 more source